Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-22 · accession 0001415889-25-002004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-23 | 2025-01-22 | TVTX | REED ELIZABETH E | SVP, GC, Corp. Sec | S - Sale | $19.46 | -2,437 | 76.9K | -3% | -$47.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | S | D | 2,437 | $19.46 | 76,933 | D | — | — | (F2) Includes 737 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 29, 2024. |